Lifeward Ltd. Ordinary Shares (LFWD)

About LFWD

Lifeward Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, Germany, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices for individuals with spinal cord injury; ReStore…

Sector

Health Care

Industry

Industrial Specialties

Employees

81

Website

golifeward.com/

Fundamentals

1-day range

$7.3$7.38

Market cap

$20.93M

P/E (trailing)

—

P/E (forward)

-8.58

EPS (trailing)

$-19.67

Dividend yield

—

Beta

0.47

Avg. volume

10.2K

Dividend pay date

April 1, 2019

Forecasts

2 analyst ratings

Lifeward Ltd. Ordinary Shares Competitors

Chosen by industry and closest market cap.

• LFWD

  Lifeward Ltd. Ordinary Shares

  $7.46

  ▲ 1.29%
  Market cap $20.93MP/E —
  $4.14$10.56
• HSCS

  HeartSciences Inc. Common Stock

  $3

  ▼ 3.85%
  Market cap $7.80MP/E —
• NTRB

  Nutriband Inc. Common Stock

  $4.51

  ▼ 2.49%
  Market cap $35.43MP/E —
  $2.8$8.63
• CLGN

  CollPlant Biotechnologies Ltd Ordinary Shares

  $0.345

  ▲ 18.97%
  Market cap $6.25MP/E —
  $0.2637$3.18
• NTRBW

  Nutriband Inc. Warrant

  $0.45

  ▼ 35.71%
  Market cap $4.25MP/E —
  $0.25$2.99
• FEED

  ENvue Medical Inc. Common Stock

  $0.3366

  ▼ 8.53%
  Market cap $3.67MP/E —
  $0.29$17.4
• MAMO

  Massimo Group Common Stock

  $1

  ▲ 0.00%
  Market cap $44.56MP/E 16.57
  $0.85$5.59

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

• Lifeward Q2 Adj. EPS $(1.46) Misses $(1.34) Estimate, Sales $6.623M Beat $6.530M Estimate
  Benzinga · 8/14/2026
• Lifeward Launches Six-Mointh Pilot Program With Ottobock Care To Enable Greater Patient Access To Its ReWalk 7 Personal Exoskeleton
  Benzinga · 8/5/2026

• Keith Dale Rose · May 1, 2026 · Grant

  15.0K
• William Mark Sigsbee · March 25, 2026 · Grant

  11.5K
• Moshe H. Rozenbaum · March 25, 2026 · Grant

  11.5K
• Adar Almog · March 25, 2026 · Grant

  39.9K
• Grant William Mark · March 25, 2026 · Grant

  172.7K
• Yehuda Reznick · March 25, 2026 · Grant

  7.7K
• Miriam Kidron · March 25, 2026 · Grant

  7.7K
• Nadav Kidron · March 25, 2026 · Grant

  7.7K